Binding studies of L-prolyl-L-leucyl-glycinamide (PLG), a novel antiparkinsonian agent, in normal human brain

Pharmacol Res Commun. 1983 Jan;15(1):41-51. doi: 10.1016/s0031-6989(83)80079-4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiparkinson Agents / metabolism*
  • Brain / metabolism*
  • Humans
  • In Vitro Techniques
  • MSH Release-Inhibiting Hormone / metabolism*
  • Membranes / metabolism
  • Receptors, Neurotransmitter / drug effects

Substances

  • Antiparkinson Agents
  • Receptors, Neurotransmitter
  • MSH Release-Inhibiting Hormone